Agilon Health, Inc. (NYSE:AGL) Given Average Rating of “Hold” by Brokerages

Agilon Health, Inc. (NYSE:AGL) has been given an average rating of “Hold” by the fifteen research firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $102.25.

A number of research analysts have weighed in on the company. Royal Bank Of Canada set a $125.00 price objective on Agilon Health in a report on Tuesday. Barclays set a $111.00 target price on shares of Agilon Health and gave the stock an “equal weight” rating in a report on Thursday, August 6th. Wells Fargo & Company reissued an “overweight” rating and issued a $146.00 price target (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Robert W. Baird set a $116.00 price target on shares of Agilon Health in a research report on Thursday, August 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th.

Agilon Health Stock Down 0.8%

AGL opened at $88.90 on Friday. Agilon Health has a twelve month low of $7.48 and a twelve month high of $133.04. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average price of $98.17 and a 200 day moving average price of $71.67. The company has a market cap of $1.49 billion, a PE ratio of -6.23 and a beta of 3.02.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Sell-side analysts expect that Agilon Health will post -2.9 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Rubicon Founders LLC purchased a new position in shares of Agilon Health during the 2nd quarter worth $11,290,448. Great Lakes Advisors LLC purchased a new stake in shares of Agilon Health in the second quarter valued at about $702,000. Alpine Global Management LLC acquired a new stake in Agilon Health during the fourth quarter worth about $84,000. Bank of New York Mellon Corp increased its position in Agilon Health by 9.5% during the second quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after purchasing an additional 3,074 shares during the last quarter. Finally, Tidal Investments LLC acquired a new stake in Agilon Health during the second quarter worth about $1,405,000.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.